MedTrace Logo

Use of Artificial Intelligence by Urogynecologic Patients

NCT06481436 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 125

Last updated 2024-12-18

No results posted yet for this study

Summary

The goal of this clinical trial is to learn about how Urogynecology patients use Artificial Intelligence (AI) Chatbots like ChatGPT, and how it affects healthcare decision making. The main question\[s\] it aims to answer are:

* How does the AI Chatbot affect participants' understanding of diagnoses and participant satisfaction with a urogynecology consultation?
* How accurate is the chatbot-provided diagnosis and counseling information? Participants will be asked to use the ChatGPT chatbot and ask it questions about the main problem the participant is seeing the doctor for, and will also be asked to fill out some questionnaires.

Researchers will compare using the Chatbot before the visit, after the visit, or not at all to see if the way participants understand the information changes based on timing of use.

Conditions

Interventions

BEHAVIORAL

Use of ChatGPT

Patients will be provided with the opportunity to ask ChatGPT questions about their primary presenting problem at a time point during their initial Urogynecology consultation visit.

Sponsors & Collaborators

  • Boston Scientific Corporation

    collaborator INDUSTRY

  • Hartford Hospital

    lead OTHER

Principal Investigators

  • Nicole J Wood, MD · Hartford Hosptial Division of Urogynecology

  • Elena Tuntisky-Bitton, MD · Hartford Hosptial Division of Urogynecology

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-22
Primary Completion
2024-12-16
Completion
2025-04-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06481436 on ClinicalTrials.gov